Literature DB >> 16368572

The role of ADP receptors in platelet function.

Swaminathan Murugappa1, Satya P Kunapuli.   

Abstract

Adenine di-Phosphate (ADP) is an important physiological agonist that plays a vital role in normal hemostasis and thrombosis. The importance of ADP in normal hemostasis is clearly demonstrated in patients suffering from storage pool disease who show excessive bleeding tendencies. It is well established that ADP activates platelets through 3 purinergic receptors, namely P2Y1, P2Y12 and P2X1. The P2Y1 receptor is a Galpha q coupled G-protein receptor that is important for platelet shape change, aggregation, thromboxane A2 generation, procoagulant activity, adhesion to immobilized fibrinogen and thrombus formation under shear conditions. The availability of P2Y1 antagonists and knockout mice have aided in demonstrating the multiple functions of this receptor in platelet function and normal hemostasis. The second ADP receptor, the P2Y12 signals through a Galpha i coupled G-protein receptor and has been shown to be important for platelet functions very similar to the P2Y1 receptor. In addition, the P2Y12 receptor is also important for potentiation of platelet activation mediated by other physiological agonists including collagen, von Willebrand and thromboxane A2. Advances in understanding the importance of the P2Y12 receptor has resulted in the development of drugs like clopidogrel and ticlopidine that is being successfully used clinically in the treatment of thrombotic disorders. The understanding of the function of this receptor has been possible due to the availability of multiple P2Y12 antagonists and the development of the P2Y12 null mice. The third and the final P2X1 receptor is an ion channel that upon activation causes an influx of calcium. Even though the activation of this receptor by itself doesn't lead to aggregation, it causes shape change and aids in the activation process of other agonists. Studies have also shown that it is important for thrombus formation under shear conditions in small arteries. Signaling by this receptor leads to significant ERK activation, which has been shown, to be important for collagen mediated platelet activation. The importance of ADP in hemostasis and thrombosis greatly underscores the significance of understanding the function of these receptors that would enable development of potent and safe anti-thrombotic drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368572     DOI: 10.2741/1939

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  42 in total

1.  Early dual antiplatelet therapy in stroke: should we take the CHANCE?

Authors:  Ethan S Brandler; Mohit Sharma
Journal:  Ann Transl Med       Date:  2015-08

2.  Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.

Authors:  Jung-Won Suh; Bon-Kwon Koo; Shu-Ying Zhang; Kyung-Woo Park; Joo-Youn Cho; In-Jin Jang; Dong-Soon Lee; Dae-Won Sohn; Myoung-Mook Lee; Hyo-Soo Kim
Journal:  CMAJ       Date:  2006-06-06       Impact factor: 8.262

3.  Determination of ATP and ADP Secretion from Human and Mouse Platelets by an HPLC Assay.

Authors:  Michael von Papen; Stepan Gambaryan; Claudia Schütz; Jörg Geiger
Journal:  Transfus Med Hemother       Date:  2013-03-15       Impact factor: 3.747

4.  P2Y12 Receptor Modulates Sepsis-Induced Inflammation.

Authors:  Elisabetta Liverani; Mario C Rico; Alexander Y Tsygankov; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-07       Impact factor: 8.311

Review 5.  Transient Receptor Potential Channels and Endothelial Cell Calcium Signaling.

Authors:  Pratish Thakore; Scott Earley
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

6.  Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI.

Authors:  Manojkumar Valiyaveettil; Niladri Kar; Mohammad Z Ashraf; Tatiana V Byzova; Maria Febbraio; Eugene A Podrez
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

7.  Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics.

Authors:  Lukas M Simon; Leonard C Edelstein; Srikanth Nagalla; Angela B Woodley; Edward S Chen; Xianguo Kong; Lin Ma; Paolo Fortina; Satya Kunapuli; Michael Holinstat; Steven E McKenzie; Jing-Fei Dong; Chad A Shaw; Paul F Bray
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

8.  Prasugrel metabolites inhibit neutrophil functions.

Authors:  Elisabetta Liverani; Mario C Rico; Analia E Garcia; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  J Pharmacol Exp Ther       Date:  2012-10-24       Impact factor: 4.030

9.  The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood.

Authors:  C Reiss; I Mindukshev; V Bischoff; H Subramanian; L Kehrer; A Friebe; J-P Stasch; S Gambaryan; U Walter
Journal:  Br J Pharmacol       Date:  2015-10-18       Impact factor: 8.739

10.  Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study.

Authors:  Evagelia C Laiakis; Gerard A J Morris; Albert J Fornace; Stephen R C Howie
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.